![](https://i0.wp.com/newcambridgeobserver.com/wp-content/uploads/2014/10/butterfly1.jpg?fit=150%2C96&ssl=1)
Cambridge-Paris Ariana Pharma reports that it has joined the WIN Consortium as an official technology partner. The Consortium (Worldwide Innovative Networking in personalized cancer medicine) is a global collaboration of 40 leading organizations whose aim is to develop more effective cancer diagnostics and therapeutics, shorten clinical trial timelines and reduce the overall cost of cancer care.